ZHAO Li, SHI Zhi-min, LI Xue-qing. Clinical Efficacy of Bupiwei Xieyinghuo Shengyang Tang Combined with Mesalazine in Treatment of Ulcerative Colitis[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(14): 188-192.
DOI:
ZHAO Li, SHI Zhi-min, LI Xue-qing. Clinical Efficacy of Bupiwei Xieyinghuo Shengyang Tang Combined with Mesalazine in Treatment of Ulcerative Colitis[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(14): 188-192. DOI: 10.13422/j.cnki.syfjx.2017140188.
Clinical Efficacy of Bupiwei Xieyinghuo Shengyang Tang Combined with Mesalazine in Treatment of Ulcerative Colitis
Objective: To observe the clinical efficacy of Bupiwei Xieyinghuo Shengyang Tang combined with mesalazine in the treatment of ulcerative colitis
and their effect on inflammatory cytokines. Method: A total of 195 patients with ulcerative colitis were selected and divided with the random number table method into control group 1
control group 2 and treatment group
with 65 cases in each group. The control group 1 was orally given mesalazin enteric-coated table
1 g/time
tid. In addition to oral administration with mesalazin enteric-coated table
the control group 2 was also orally given Chenliji Bupi Yichang pill
6 g/time
tid. The treatment group was treated with Bupiwei Xieyinghuo Shengyang Tang
100 mL/time
tid
in addition to oral administration with mesalazin enteric-coated table. Before and after treatment
symptoms
colorectal mucosa score changes
high sensitivity C-reaction protein (hs-CRP)
interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels were observed
and statistics was made for the clinical efficacy. Result: The treatment group showed reductions in symptoms (abdominal pain
diarrhea
pus and blood stool)
colon mucosa score
cytokines (hs-CRP
IL-6
TNF-alpha) compared with control group 1 and control group 2 (P<0.05). The total effective rates of treatment group
control group 1 and control group 2 were 93.85%
78.46%
81.54%
respectively
indicating treatment group was superior to control group 1 and control group 2 in the clinical efficacy (P<0.05). Conclusion: Bupiwei Xieyinghuo Shengyang Tang combined with mesalazine can effectively alleviate clinical symptoms of ulcerative colitis and colorectal mucosa
improve the level of cytokines
and provide an effective prescription for clinical explorations for traditional Chinese medicine for the treatment of ulcerative colitis
Clinical Observation of Qushi Qingchang Recipe Combined with Chinese Medicine for Treating Mild-to-moderate Ulcerative Colitis with Syndrome of Dampness-heat in Large Intestine
Effect of Gegen Qinlian Tang on CRP, TNF-alpha and IL-6 in Diabetic ZDF Rats
Effect of Bushen Huoxue Decoction on Coagulation Function and Inflammatory Reaction of Patients with Intrauterine Adhesions After Surgery
Effect and Mechanism of Action of Shenshuaining Tablet to Prognosis of Patients at CKD3-4 Period
Effect of Suhuang Zhike Decoction on IL-6 and TNF- Levels in Patients with Cough Variant Asthma
Related Author
FENG Zhuo
HAN Chang-peng
LI Ying
WANG Zhen-yi
YANG Hao-jie
WANG Ye
ZHU Xiang-dong
WU Dan
Related Institution
Jiangxi University of Chinese Medicine
College of Food Science and Technology,Nanchang University
School of Life Sciences,Beijing University of Chinese Medicine
School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine(TCM)
School of Basic Medical Sciences, Guangzhou University of Chinese Medicine